Real Money authors - Jim Collins

Jim Collins

Jim Collins is the Founding Partner of Portfolio Guru. Collins researches small stocks in his newsletter, MicroCap Guru, and uses income-investing principles to manage money for individuals on a fee-only, separately-managed account basis.

Previously, Collins spent 10 years as an equity analyst in New York and London covering the automotive sector for Lehman Brothers, Donaldson, Lufkin & Jenrette and UBS. He holds an A.B. in Economics and History from Duke University and has completed the academic requirements for the CFA designation. 

Email Jim Collins

Recent Articles By The Author

The Most Lucrative Moment in Investing Is an Inflection Point

Playing the move after an inflection point, directionally, is the way to make money trading, as opposed to investing.

Listen to Mr. Market, Not Mr. Powell

Let's look at bonds, rates and, especially, inflation for a true picture of what's going on, and where to put your money.

Ring the Cowbell: Here Are Three Ways to Play the Jittery Market

Let's look at the move in bonds, how it will lead stocks -- and load the deck with some 'b-sides.'

Here's the Real Reason Bulls Should Fear Higher Interest Rates

Low borrowing costs have fueled the boom in stocks, and higher borrowing costs can just as surely kill it.

As Texas Freezes, the Solution Is More Natural Gas

My favorite natgas play has been Antero Midstream, approaching a 300% gain since last March.

Tesla in India? Not a Chance

And listen to what Cathie Wood of ARK Investments had to say about TSLA and ride sharing.

The UK's Bubble Isn't Bigger Than Ours, but It's Still a Bubble

In the current scenario I can understand why someone would want to buy bitcoin. But here's what I do.

Grow Your Portfolio's Footprint With Energy

Let's look at Exxon, energy exchange-traded funds and an Italian name that shows promise.

There's No Use Crying About Stagflation, Profit From It!

With what's going on, Adam Smith just rolled over in his grave.

The Game Has Dramatically Changed for Jaguar Health

JAGX has a drug that is impactful against a key symptom of Covid-19 long-hauler syndrome.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight